Labs / Assays & in vitro testing

Ainnocence
Mountain View, CA, United States · ainnocence.com
GLP
Ainnocence is a biotech company that uses AI and wet-lab validation to design antibodies, small molecules, peptides, cell therapies, natural products, and RNA therapeutics. It works with pharma partners on target-specific discovery programs from sequence data, with offices in the Bay Area. The company says it provides validated, licensable candidates and freedom-to-operate analysis.
They take quote requests by email.
What they offer
SentinusAI
Antibody design and protein engineering, including de novo antibody design, affinity maturation, bispecific and multispecific engineering, and format conversion.
CarbonAI
De novo small-molecule generation, PROTAC design, scaffold hopping, and CRBN neosubstrate selectivity panel design.
CellulaAI
CAR construct optimization and modeling for CAR-T, allogeneic cell therapies, and gene-edited cellular products.
PeptideAI
Design of peptide therapeutics, including cyclic, stapled, and GLP-1 analogs, with sequence optimization.
NatmolAI
Computational expansion and optimization of natural-product chemical space, including scaffold library mining and semi-synthetic analog generation.
SenseAI
Design of RNA therapeutics, including mRNA, siRNA, and ASOs, with sequence-based optimization.
Custom target engagements
Partnering service in which the company assembles the needed platforms for a target and delivers wet-lab-validated candidates with freedom-to-operate analysis.
What they work on
- Modalities
- Small molecule, Antibody, Bispecific, Peptide, Oligonucleotide, mRNA, Cell therapy
- Species and models
- IgG, Fab, scFv, VHH, bispecifics, CRBN neosubstrate panels
- Assays and studies
- affinity prediction, generative design, virtual screening, wet-lab validation, activation prediction, persistence modeling, secondary structure prediction, stability modeling, efficacy ranking, selectivity panels
- Scale and capacity
- 167M-parameter protein foundation model (AINN-P1), screen up to 10 billion protein sequences or chemical compounds within hours, 1M+ antibody variants evaluated, 10^10 compounds overnight, 3.2M peptide screens, 40 validated targets, 2,872 molecules experimentally tested in wet lab
- Therapeutic areas
- drug discovery, precision medicine, oncology
- Turnaround
- overnight · typically in weeks, not quarters · within a week
- What to send
- Bring us a target · Pick a target you care about
- Sites
- Bay Area, USA
- Quality
- wet-lab validated · patentable IP · freedom-to-operate analysis
- Address
- 3 Tn Ln;x 7x묊btfzk q¾L 9N~֫c3\q7ߠMjh'
- Founded
- 2021
Similar labs. Olympic Protein Technologies, Akeagen, Aurigene Pharmaceutical Services, Evotec
Found in a contract services directory. Listing built from ainnocence.com. Work here? Claim this listing.